Resveratrol augments nitric oxide generation and causes store calcium release in chromaffin cells

European Journal of Pharmacology

Volumn 685, Issue 1-3, 2012, Pages 99-107

  Padín, Juan Fernando ^a,b   De Diego, Antonio M G ^a,b   Fernández Morales, José Carlos ^a,b   Merino, Cristina ^a,b   Maroto, Marcos ^a,b   Calvo Gallardo, Enrique ^a,b   Arranz, Juan Alberto ^a,b,c   Yáñez, Matilde ^a,b,c   García, Antonio G ^a,b  

^a INSTITUTO TEÓFILO HERNANDO   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Calcium; Chromaffin cell; Exocytosis; Hypertension; Nitric oxide; Resveratrol

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CALCIUM ION; DANTROLENE; FURA 2 ACETOXYMETHYL ESTER; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; RESVERATROL; RYANODINE;

ANIMAL CELL; ARTICLE; CALCIUM DEPLETION; CALCIUM TRANSPORT; CHROMAFFIN CELL; CONTROLLED STUDY; COW; DRUG EFFECT; DRUG MECHANISM; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; FLUORESCENCE; MOLECULAR DYNAMICS; MOLECULAR PROBE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADRENAL MEDULLA; ANIMALS; ANTIOXIDANTS; CALCIUM; CATTLE; CHROMAFFIN CELLS; EXOCYTOSIS; FLUORESCENT DYES; FURA-2; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRITES; S-NITROSO-N-ACETYLPENICILLAMINE; SIGNAL TRANSDUCTION; STILBENES;

EID: 84861346095     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.03.040     Document Type: Article

References (47)

1. 2+ release in chromaffin cells seen from inside the ER with targeted aequorin J. Cell Biol. 144 1999 241 254
2. J.J. Arnaiz-Cot, A.M. de Diego, J.M. Hernandez-Guijo, L. Gandia, and A.G. Garcia A two-step model for acetylcholine control of exocytosis via nicotinic receptors Biochem. Biophys. Res. Commun. 365 2008 413 419
3. A. Bertelli Pharmacokinetics and metabolism of resveratrol B.B. Aggarwal, M. Chandra, S. Shishodia, Resveratrol in Health and Disease 2006 CRC Press, Taylor & Francis Group New York, NY 631 647
4. A.A. Bertelli, L. Giovannini, W. Bernini, M. Migliori, M. Fregoni, L. Bavaresco, and A. Bertelli Antiplatelet activity of cis-resveratrol Drugs Exp. Clin. Res. 22 1996 61 63
5. S. Bradamante, L. Barenghi, and A. Villa Cardiovascular protective effects of resveratrol Cardiovasc. Drug Rev. 22 2004 169 188
6. 2+ handling in A7r5 vascular myocytes Eur. J. Pharmacol. 577 2007 91 99
7. S. Christensen, M.B. Johansen, E. Tonnesen, A. Larsson, L. Pedersen, S. Lemeshow, and H.T. Sorensen Preadmission beta-blocker use and 30-day mortality among patients in intensive care: a cohort study Crit. Care 15 2011 R87
8. A.M. de Diego, L. Gandia, and A.G. Garcia A physiological view of the central and peripheral mechanisms that regulate the release of catecholamines at the adrenal medulla Acta Physiol (Oxf.) 192 2008 287 301
9. K.E. Dittenhafer-Reed, J.L. Feldman, and J.M. Denu Catalysis and mechanistic insights into sirtuin activation Chembiochem 12 2011 281 289
10. J.C. Fernández-Morales, M. Yáñez, F. Orallo, L. Cortés, J.C. González, J.M. Hernández-Guijo, A.G. García, and A.M. de Diego Blockade by nanomolar resveratrol of quantal catecholamine release in chromaffin cells Mol. Pharmacol. 78 2010 734 744
11. D. Fulton, J.P. Gratton, T.J. McCabe, J. Fontana, Y. Fujio, K. Walsh, T.F. Franke, A. Papapetropoulos, and W.C. Sessa Regulation of endothelium-derived nitric oxide production by the protein kinase Akt Nature 399 1999 597 601
12. A.G. García, F. Sala, J.A. Reig, S. Viniegra, J. Frías, R. Fontériz, and L. Gandía Dihydropyridine BAY-K-8644 activates chromaffin cell calcium channels Nature 309 1984 69 71
13. P. Gresele, C. Cerletti, G. Guglielmini, P. Pignatelli, G. de Gaetano, and F. Violi Effects of resveratrol and other wine polyphenols on vascular function: an update J. Nutr. Biochem. 22 2011 201 211
14. D.M. Kaye, J. Lefkovits, G.L. Jennings, P. Bergin, A. Broughton, and M.D. Esler Adverse consequences of high sympathetic nervous activity in the failing human heart J. Am. Coll. Cardiol. 26 1995 1257 1263
15. C.M. Klinge, N.S. Wickramasinghe, M.M. Ivanova, and S.M. Dougherty Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells FASEB J. 22 2008 2185 2197
16. T. Krause, M.U. Gerbershagen, M. Fiege, R. Weisshorn, and F. Wappler Dantrolene: a review of its pharmacology, therapeutic use and new developments Anaesthesia 59 2004 364 373
17. +-evoked secretion in chromaffin cells Am. J. Physiol. 272 1997 C1211 C1221
18. H.F. Li, Z.F. Tian, X.Q. Qiu, J.X. Wu, P. Zhang, and Z.J. Jia A study of mechanisms involved in vasodilatation induced by resveratrol in isolated porcine coronary artery Physiol. Res. 55 2006 365 372
19. Z. Liu, L.P. Zhang, H.J. Ma, C. Wang, M. Li, and Q.S. Wang Resveratrol reduces intracellular free calcium concentration in rat ventricular myocytes Sheng Li Xue Bao 57 2005 599 604
20. M.G. López, F. Abad, C. Sancho, R. de Pascual, R. Borges, R. Maroto, W. Dixon, and A.G. Garcia Membrane-mediated effects of the steroid 17-alpha-estradiol on adrenal catecholamine release J. Pharmacol. Exp. Ther. 259 1991 279 285
21. A. Lymperopoulos, G. Rengo, and W.J. Koch Adrenal adrenoceptors in heart failure: fine-tuning cardiac stimulation Trends Mol. Med. 13 2007 503 511
22. J.D. Machado, F. Segura, M.A. Brioso, and R. Borges Nitric oxide modulates a late step of exocytosis J. Biol. Chem. 275 2000 20274 20279
23. I. Mattagajasingh, C.S. Kim, A. Naqvi, T. Yamamori, T.A. Hoffman, S.B. Jung, J. DeRicco, K. Kasuno, and K. Irani SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase Proc. Natl. Acad. Sci. U. S. A. 104 2007 14855 14860
24. 2+ transients that modulate secretion Nat. Cell Biol. 2 2000 57 61
25. M.A. Moro, M.G. López, L. Gandía, P. Michelena, and A.G. García Separation and culture of living adrenaline- and noradrenaline-containing cells from bovine adrenal medullae Anal. Biochem. 185 1990 243 248
26. M.A. Moro, P. Michelena, P. Sánchez-García, R. Palmer, S. Moncada, and A.G. García Activation of adrenal medullary l-arginine: nitric oxide pathway by stimuli which induce the release of catecholamines Eur. J. Pharmacol. 246 1993 213 218
27. F. Orallo Comparative studies of the antioxidant effects of cis- and trans-resveratrol Curr. Med. Chem. 13 2006 87 98
28. F. Orallo Trans-resveratrol: a magical elixir of eternal youth? Curr. Med. Chem. 15 2008 1887 1898
29. F. Orallo, E. Alvarez, M. Camiña, J.M. Leiro, E. Gómez, and P. Fernández The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption Mol. Pharmacol. 61 2002 294 302
30. M.J. Oset-Gasque, M. Parramón, S. Hortelano, L. Boscá, and M.P. González Nitric oxide implication in the control of neurosecretion by chromaffin cells J. Neurochem. 63 1994 1693 1700
31. M.J. Oset-Gasque, S. Vicente, M.P. González, L.M. Rosario, and E. Castro Segregation of nitric oxide synthase expression and calcium response to nitric oxide in adrenergic and noradrenergic bovine chromaffin cells Neuroscience 83 1998 271 280
32. S.V. Penumathsa, and N. Maulik Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease Can. J. Physiol. Pharmacol. 87 2009 275 286
33. C. Plin, J.P. Tillement, A. Berdeaux, and D. Morin Resveratrol protects against cold ischemia-warm reoxygenation-induced damages to mitochondria and cells in rat liver Eur. J. Pharmacol. 528 2005 162 168
34. S. Renaud, and M. de Lorgeril Wine, alcohol, platelets, and the French paradox for coronary heart disease Lancet 339 1992 1523 1526
35. P.M. Schwarz, F. Rodríguez-Pascual, D. Koesling, M. Torres, and U. Förstermann Functional coupling of nitric oxide synthase and soluble guanylyl cyclase in controlling catecholamine secretion from bovine chromaffin cells Neuroscience 82 1998 255 265
36. Y. Shinohara, Y. Toyohira, S. Ueno, M. Liu, M. Tsutsui, and N. Yanagihara Effects of resveratrol, a grape polyphenol, on catecholamine secretion and synthesis in cultured bovine adrenal medullary cells Biochem. Pharmacol. 74 2007 1608 1618
37. S. Vicente, M.P. González, and M.J. Oset-Gasque Neuronal nitric oxide synthase modulates basal catecholamine secretion in bovine chromaffin cells J. Neurosci. Res. 69 2002 327 340
38. S. Vicente, S. Figueroa, R. Pérez-Rodríguez, M.P. González, and M.J. Oset-Gasque Nitric oxide donors induce calcium-mobilisation from internal stores but do not stimulate catecholamine secretion by bovine chromaffin cells in resting conditions Cell Calcium 37 2005 163 172
39. L. von Ruden, and E. Neher A Ca-dependent early step in the release of catecholamines from adrenal chromaffin cells Science 262 1993 1061 1065
40. T. Walle, F. Hsieh, M.H. DeLegge, J.E. Oatis Jr., and U.K. Walle High absorption but very low bioavailability of oral resveratrol in humans Drug Metab. Dispos. 32 2004 1377 1382
41. E. Wenzel, and V. Somoza Metabolism and bioavailability of trans-resveratrol Mol. Nutr. Food Res. 49 2005 472 481
42. S.C. Woo, G.M. Na, and D.Y. Lim Resveratrol inhibits nicotinic stimulation-evoked catecholamine release from the adrenal medulla Korean J. Physiol. Pharmacol. 12 2008 155 164
43. J.M. Wu, and T.C. Hsieh Resveratrol: a cardioprotective substance Ann. N. Y. Acad. Sci. 1215 2011 16 21
44. J.M. Wu, Z.R. Wang, T.C. Hsieh, J.L. Bruder, J.G. Zou, and Y.Z. Huang Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine Int. J. Mol. Med. 8 2001 3 17
45. J. Xi, H. Wang, R.A. Mueller, E.A. Norfleet, and Z. Xu Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore Eur. J. Pharmacol. 604 2009 111 116
46. 2+ release channel in visceral smooth muscle Proc. Natl. Acad. Sci. U. S. A. 91 1994 3294 3298
47. L.P. Zhang, J.X. Yin, Z. Liu, Y. Zhang, Q.S. Wang, and J. Zhao Effect of resveratrol on L-type calcium current in rat ventricular myocytes Acta Pharmacol. Sin. 27 2006 179 183